The CTN 214 clinical trial team: (left to right) Dr. Brian Conway and Shelley Fleming (DIDC), Natasha LaPierre (CTN National Centre), Linda Apuzzo and Dr. Joseph Margolick (Johns Hopkins).
Therapy on the brink: experienced researchers launch naïve test
Since the availability of triple-drug therapy in the mid 1990s, experts have debated whether or not to treat acute and early HIV infection. A new study joins
the discourse with—quite literally—a pre-emptive strike.
Five awards of $45,000 plus a yearly travel allowance of $3,000 are available through the CTN Postdoctoral Fellowship Awards Programme for the 2007-2008 cycle.
One of the fellowships is being generously sponsored by Hoffman-La Roche for the next three years. The deadline for submissions is January 31, 2007.
Read more in Connections
Find out more
